logo
Sign In
  1. Home
  2. Indications
  3. Rhinitis Vasomotor

Medications for Rhinitis Vasomotor

FiltersReset Filters
17 results

  • azelastine hydrochloride

    (Azelastine)
    Medication Details
    AvKARE
    Usage: Azelastine hydrochloride nasal spray, 0.1%, is indicated for treating symptoms of seasonal allergic rhinitis in individuals 5 years and older, and for vasomotor rhinitis in those 12 years and older.
    Medication Details
    Drug Interactions

  • azelastine hydrochloride

    (AZELASTINE HYDROCHLORIDE)
    Medication Details
    Aurobindo Pharma Limited
    Usage: Azelastine hydrochloride Nasal Spray is indicated for treating seasonal allergic rhinitis in adults and children aged 5 and older, as well as vasomotor rhinitis in adults and adolescents aged 12 and older.
    Medication Details
    Drug Interactions

  • brisdelle

    (paroxetine)
    Medication Details
    Legacy Pharma USA, Inc.
    Usage: BRISDELLE is indicated for treating moderate to severe vasomotor symptoms associated with menopause. It is not approved for psychiatric conditions, and its lower dosage for menopause is not established for any psychiatric use. Patients needing paroxetine for psychiatric issues should switch to a suitable paroxetine product.
    Medication Details

  • carbinoxamine maleate

    (CARBINOXAMINE MALEATE)
    Medication Details
    BluCrest Pharmaceuticals, LLC
    Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations, dermatographism, and as an adjunctive therapy for anaphylactic reactions and allergic reactions to blood or plasma.
    Medication Details
    Drug Interactions

  • carbinoxamine maleate

    (Carbinoxamine Maleate)
    Medication Details
    Biocomp Pharma, Inc.
    Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, dermatographism, as adjunct therapy for anaphylactic reactions, and to reduce the severity of allergic reactions to blood or plasma.
    Medication Details
    Drug Interactions

  • cyproheptadine hydrochloride

    (Cyproheptadine Hydrochloride)
    Medication Details
    Bayshore Pharmaceuticals LLC
    Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, cold urticaria, dermatographism, and as adjunctive therapy for anaphylactic reactions after initial control with epinephrine.
    Medication Details
    Drug Interactions

  • cyproheptadine hydrochloride

    (Cyproheptadine Hydrochloride)
    Medication Details
    Rising Pharma Holdings, Inc.
    Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, ameliorating allergic reactions to blood, and as an adjunctive therapy for anaphylactic reactions after acute management.
    Medication Details
    Drug Interactions

  • cyproheptadine hydrochloride

    (Cyproheptadine Hydrochloride)
    Medication Details
    Patrin Pharma, Inc.
    Usage: The drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial treatment with epinephrine and standard measures.
    Medication Details
    Drug Interactions

  • cyproheptadine hydrochloride

    (Cyproheptadine Hydrochloride)
    Medication Details
    Amneal Pharmaceuticals of New York LLC
    Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, amelioration of allergic reactions to blood, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial management.
    Medication Details
    Drug Interactions

  • duavee

    (conjugated estrogens/bazedoxifene)
    Medication Details
    Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
    Usage: DUAVEE is indicated for women with a uterus to treat moderate to severe menopausal vasomotor symptoms and to prevent postmenopausal osteoporosis. Treatment duration should be minimal and reconsidered periodically, focusing on women at significant risk of osteoporosis.
    Medication Details
    Drug Interactions
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.